Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
14.96
+0.84 (5.95%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Anika Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
57.4855.6368.7486.3394.39
Cash & Short-Term Investments
57.4855.6368.7486.3394.39
Cash Growth
3.33%-19.07%-20.37%-8.54%-4.00%
Accounts Receivable
23.6923.5926.3634.6329.84
Inventory
18.7923.8124.4339.7736.01
Other Current Assets
3.410.6243.788.838.29
Total Current Assets
103.36113.65163.31169.55168.53
Net Property, Plant & Equipment
66.2664.686578.9868.56
Other Intangible Assets
1.652.492.5874.682.38
Goodwill
8.057.137.577.347.78
Other Long-Term Assets
10.9514.7932.1818.6720.29
Total Assets
190.27202.74270.63349.13347.54
Accounts Payable
6.045.626.199.077.63
Accrued Expenses
15.8713.5714.0718.8417.85
Other Current Liabilities
-4.1210.8-4.32
Total Current Liabilities
21.9123.3131.0627.9129.8
Long-Term Leases
24.224.0125.9228.8219.24
Other Long-Term Liabilities
0.71.431.396.8311.42
Total Long-Term Liabilities
24.925.4527.3135.6530.66
Total Liabilities
46.8148.7558.3763.5760.45
Common Stock
0.140.140.150.150.14
Additional Paid-in Capital
87.588.9690.0181.1467.08
Accumulated Other Comprehensive Income
-4.96-6.78-5.94-6.44-5.72
Retained Earnings
60.7971.67128.05210.72225.58
Shareholders' Equity
143.47153.99212.27285.56287.09
Total Liabilities & Equity
190.27202.74270.63349.13347.54
Total Debt
24.224.0125.9228.8219.24
Net Cash (Debt)
33.2931.6242.8357.5175.15
Net Cash Growth
5.28%-26.18%-25.54%-23.47%-2.96%
Net Cash Per Share
2.322.152.923.895.13
Book Value
143.47153.99212.27285.56287.09
Book Value Per Share
10.0110.4614.4819.3119.62
Tangible Book Value
133.76144.37202.12203.63196.92
Tangible Book Value Per Share
9.339.8113.7913.7713.46
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q